Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Closes $5 Million Series B Financing

NEW YORK, Jan. 24 (GenomeWeb News) - OpGen said today that it has closed a series B financing round, raising a total of $5 million.


Investors in the financing included Mason Wells Biomedical Fund, Stonehenge Capital, the State of Wisconsin Investment Board, and the Wisconsin Alumni Research Foundation, according to the company.


OpGen said that the proceeds of the financing will be used to expand its marketing and sales infrastructure, conduct commercial service collaborations and contracts, and accelerate commercialization of its optical mapping genome comparison technology.